Cristina Santoro | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Incidence of Early Thrombosis in Myeloproliferative Neoplasms (MPN): A Prospective Analysis from the Gruppo Laziale of Ph-Negative MPN	BLOOD	2016
Application of global coagulation assays in hemophilia B patients to evaluate the hemostatic potential in baseline conditions and after FIX concentrate administration	JOURNAL OF THROMBOSIS AND HAEMOSTASIS	2016
How the Real-Life Diagnostic and Therapeutic Approach Changed in the Last Two Decades in the Thrombocythemic Patients with Ph-Negative Myeloproliferative Neoplasm. Report on 2388 Subjects of the Registro Italiano Trombocitemie (RIT)	BLOOD	2016
Essential Thrombocythemia: A Comparison of Overall and Thrombosis Free Survival in Two Discrete Periods of the First Decade of 2000. a Retrospective Analysis	BLOOD	2016
Thrombin generation assay (TGA) for testing haemostatic response in patients with Hemophilia A and inhibitors on immune tolerance induction treatment (ITI): Preliminary in vivo results from the PredicTGA study	HAEMOPHILIA	2016
Investigation of possible correlation between clinical and laboratory phenotype in congenital FXI deficiency: results from a single center	HAEMOPHILIA	2016
Health Status of Elderly Persons with Hemophilia Compared with the General Population: The Sphera Study	HAEMOPHILIA	2016
Application of global coagulation assays in Hemophilia B patients to evaluate the hemostatic potential in baseline conditions and after FIX concentrate administration	HAEMOPHILIA	2016
Investigation of possible correlation between clinical and laboratory phenotype in congenital FXI deficiency: results from a single center	JOURNAL OF THROMBOSIS AND HAEMOSTASIS	2016
Investigation of Possible Correlation Between Clinical and Laboratory Phenotype in Congenital FXI Deficiency: Results from a Single Center	HAEMOPHILIA	2016
Maternal thrombophilia and adverse pregnancy outcome: a case-control study	ACTA HAEMATOLOGICA	2015
Are ET and PV Patients Two Similar Populations As Concern Thrombotic Risk Factors?	BLOOD	2015
Application of the International Prognostic Score of Thrombosis for Essential Thrombocytemia(ET) (IPSET-Thrombosis) in a Cohort of ET Patients: Experience from Gruppo Laziale for Myeloproliferative Ph Negative Neoplasms	BLOOD	2015
Health-Related Quality of Life in Patients with Primary Immune Thrombocytopenia (pITP): Investigating Differences Amongst Newly Diagnosed, Persistent and Chronic Pitp Patients	BLOOD	2015
Clinical and Biological Features in Patients with Ph-Negative Chronic Myeloproliferative Neoplasm Showing Different Molecular Pattern. Comparative Study in 596 Patients of the Registro Italiano Trombocitemie (RIT)	BLOOD	2015
The Platelet COUNT at Diagnosis of Essential Thrombocythemia Is a Prognostic Factor for Thrombosis-Free Survival: Retrospective Analysis on 1201 Patients	BLOOD	2015
TPO-RECEPTOR AGONISTS AS TREATMENT PREPARING ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA TO SPLENECTOMY. RESULTS OF A RETROSPECTIVE, OBSERVATIONAL STUDY (GIMEMA ITP0614)	HAEMATOLOGICA	2015
THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS AFFECTED BY PRIMARY IMMUNE THROMBOCYTOPENIA: ANALYSIS OF POSSIBLE PREDICTIVE FACTORS FOR SUSTAINED AND DURABLE RESPONSE FROM A RETROSPECTIVE CASE SERIES	HAEMATOLOGICA	2015
ROLE OF TREATMENT ON THE DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ESSENTIAL THROMBOCYTEMIA	HAEMATOLOGICA	2015
SPLEEN ENLARGEMENT IS A RISK FACTOR FOR THROMBOSIS IN ESSENTIAL THROMBOCYTHEMIA: EVALUATION ON 1097 PATIENTS AND VALIDATION ON 792 PATIENTS	HAEMATOLOGICA	2015